Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)) and Ranibizumab ophthalmic
Determining the interaction of Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)) and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS))-Ranitidine
- Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS))-Ranitidine Capsule
- Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS))-Ranitidine Hydrochloride
- Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS))-Ranitidine Injection
- Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS))-Ranitidine Suspension
- Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS))-Ranitidine Syrup
- Ranibizumab ophthalmic-Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))
- Ranibizumab ophthalmic-Nuwiq recombinant
- Ranibizumab ophthalmic-NuZole
- Ranibizumab ophthalmic-Nuzyra
- Ranibizumab ophthalmic-Nuzyra (Omadacycline Injection)
- Ranibizumab ophthalmic-Nuzyra (Omadacycline Tablets)